ImmunityBio (26CA.STU) Q2 2026 Earnings

7MayConfirmed
Q2 2026
-0.53
-0.37
-0.22
-0.06

Details

Expected EPS
-0.0600791282
Actual EPS
-0.5286554
Surprise EPS
-0.47
Surprise Percent
+779.93%

Description

ImmunityBio (26CA.STU) has reported earnings of -0.5286554 per share for Q2 2026.

0 Comments

Share your thoughts